Cargando…

Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression

OBJECTIVES: This study was aimed to investigate the efficacy and safety of vortioxetine hydrobromide in the treatment of major depressive disorder (MDD). METHODS: One hundred and eighty patients with the newly diagnosed depression in our hospital between August 2018 and August 2019 were selected and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Shichuan, Sun, Baomin, Sun, Huiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247771/ https://www.ncbi.nlm.nih.gov/pubmed/35799757 http://dx.doi.org/10.12669/pjms.38.5.5230

Ejemplares similares

Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial
por: Shin, Cheolmin, et al.
Publicado: (2023)

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
por: Lee, Seung-Hoon, et al.
Publicado: (2022)

Comparative efficacy and safety of escitalopram, desvenlafaxine, and vortioxetine in the acute treatment of anxious depression: A randomized rater-blinded, 6-week clinical trial
por: Oh, K.-S., et al.
Publicado: (2022)

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
por: Lee, Seung-Hoon, et al.
Publicado: (2022)

Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram
por: Chakroborty, Shreaya, et al.
Publicado: (2017)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43
por: Shiroyama, Takashi, et al.
Publicado: (2021)

Efficacy of vortioxetine on the physical symptoms of major depressive disorder
por: Christensen, Michael Cronquist, et al.
Publicado: (2018)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2014)

Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor
por: Okada, Motohiro, et al.
Publicado: (2021)

Escitalopram, bupropion, lurasidone, lamotrigine and possible vortioxetine overdose presented with serotonin syndrome and diffuse encephalopathy: A case report
por: Thumtecho, Suthimon, et al.
Publicado: (2021)

Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats
por: Leiser, S C, et al.
Publicado: (2014)

Efficacy of escitalopram oxalate for patients with post-stroke depression
por: Xu, Ji-hua, et al.
Publicado: (2018)

Vortioxetine Treatment for Depression in Alzheimer’s Disease: A Randomized, Double-blind, Placebo-controlled Study
por: Jeong, Hye Won, et al.
Publicado: (2022)

Efficacy of hyperbaric oxygen combined with escitalopram in depression and its effect on cognitive function
por: Mi, Kun, et al.
Publicado: (2021)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
por: Gammoh, Omar, et al.
Publicado: (2023)

P.0370 Escitalopram efficacy in post-covid depression treatment: a pilot study
por: Chaban, O., et al.
Publicado: (2021)

Efficacy of escitalopram for poststroke depression: a systematic review and meta-analysis
por: Feng, Rong-fang, et al.
Publicado: (2022)

Clinical efficacy and safety of Guipi decoction combined with escitalopram oxalate tablets in patients with depression
por: Yu, Jia, et al.
Publicado: (2023)

The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
por: Li, Guangjian, et al.
Publicado: (2016)

The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis
por: Meeker, Amanda S, et al.
Publicado: (2015)

Emotional blunting and cognitive profile in elderly depressed patients in treatment with vortioxetine
por: Franza, F., et al.
Publicado: (2021)

Clinical effectiveness of vortioxetine in postcovid syndrome
por: Vikarenko, M., et al.
Publicado: (2022)

Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
por: Segura-Garcia, Cristina, et al.
Publicado: (2021)

Efficacy of escitalopram monotherapy in the treatment of major depressive disorder: A pooled analysis of 4 Chinese clinical trials
por: Li, Guanjun, et al.
Publicado: (2017)

Sexual functioning in females with depression in remission receiving escitalopram
por: Roy, Pritha, et al.
Publicado: (2019)

Predicting escitalopram monotherapy response in depression: The role of anterior cingulate cortex
por: Tian, Shui, et al.
Publicado: (2019)

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions
por: Chen, Grace, et al.
Publicado: (2017)

Depression and Cerebrovascular Disease: Could Vortioxetine Represent a Valid Treatment Option?
por: Carta, Mauro Giovanni, et al.
Publicado: (2015)

Comparing the Therapeutic Effects of Crocin, Escitalopram and Co-Administration of Escitalopram and Crocin on Learning and Memory in Rats with Stress-Induced Depression
por: Joodaki, Mehran, et al.
Publicado: (2021)

The effect of vortioxetine on overall patient functioning in patients with major depressive disorder
por: Florea, Ioana, et al.
Publicado: (2017)

Mild cognitive disorder and depression: treatment with combination of galantamine and escitalopram
por: Zarra, Julio, et al.
Publicado: (2010)

Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research
por: Bennabi, Djamila, et al.
Publicado: (2019)

Effects of Vortioxetine on Sleep Architecture of Adolescents with Major Depressive Disorder
por: Mlyncekova, Zuzana, et al.
Publicado: (2023)

Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series
por: Siwek, Marcin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lvc8opnadd8lu87sdvmrerpgfo